117 Views

Water Street and JLL Partners completes merger of CCBR-SYNARC and BioClinica

Water Street Healthcare Partners and JLL Partners said Wednesday that they have completed the merger of CCBR-SYNARC and BioClinica. No financial terms were disclosed. Both Water Street and JLL Partners have named Jeffrey McMullen to serve as chairman of the combined company, which will provide specialty outsourced clinical services.

113 Views

JLL Partners and Royal DSM complete Dpx Holdings transaction

JLL Partners and Royal DSM, a global life sciences and materials sciences company have closed the transaction announced in November 2013 combining DSM Pharmaceutical Products and Patheon Inc into a new privately held company named DPx Holdings. With headquarters in Durham, N.C., DPX’s global footprint includes 24 global locations across North America, Europe, Latin America and Australia.

BioClinica and CoreLabs Merged into BioClinica

After their purchase of BioClinica, a clinical train management services firm, and the medical imaging and cardiac safety services company CoreLab Partners, middle market firms JLL Partners and Ampersand Capital Partners have combined the two companies under the name BioClinica.

BioClinica Announces Its Tender Offer is Complete

BioClinica, a Newton, Pa.-based clinical trials management company, and JLL Partners, a New York private equity firm, announced that they’ve successfully completed the tender offer by BC Acquisition Corp., an affiliate of JLL Partners that last month began a $7.25 per share offer for all outstanding shares of BioClinica. In January, JLL agreed to acquire BioClinica for $123 million.

Tender Offer Commences for BioClinica

BioClinica and JLL Partners have announced that BC Acquisition Corp has commenced a tender offer for all outstanding shares of BioClinica at a price of $7.25 per share net to the seller in cash. BioClinica is a provider of clinical trial management solutions.

JLL Partners Completes American Dental Deal

JLL Partners, the New York-based private equity firm, completed its acquisition of American Dental Partners, the Massachusetts-based dental group practice with operations in 21 states. Specifics of the deal were not publicized; JLL’s Michael Lagarde, a managing director with the firm, worked on the transaction. PRESS RELEASE: JLL Partners, Inc. (“JLL”) and American Dental Partners, […]

102 Views

HealthCor Partners Out Seeking $300M For Fund II

HealthCor Partners Management, an investor in fast-growing health care and life sciences companies, is out seeking $300 million—a tally that would double the firm’s assets under management if achieved. The New York-based firm is part of the HealthCor Group, a hedge-fund manager and private equity shop with more than $3 billion under management. According to […]

Patheon Appoints Lagarde to Board

Patheon, a provider of contract development and manufacturing services to the global pharmaceutical industry, has appointed Michel Lagarde, principal, JLL Partners, to its board of directors. Lagarde replaces Thomas S. Taylor, managing director, JLL Partners, who is leaving the board. PRESS RELEASE Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services […]

ADP Goes Ahead with JLL Partners

Dental group practice American Dental Partners has announced the expiration of the 40-day “go-shop” period during which the company solicited alternative proposals to the acquisition of the company by JLL Partners. After a broad solicitation of financial and strategic parties during the period, the company did not receive any acquisition proposals. The company expects the […]

JLL Backs American Dental Partners

JLL Partners is acquiring American Dental Partners for approximately $398 million, including $81 million in currently outstanding debt. American Dental Partners is a leading business partner to dental group practices. The company is affiliated with 27 dental group practices, which have 282 dental facilities with approximately 2,404 operatories in 21 states. PRESS RELEASE American Dental […]

Slideshow: More LBO Targets In The CRO Market

The Carlyle Group and Hellman & Friedman’s $3.9 billion agreement to buy Pharmaceutical Product Development Inc. marks the latest example of buyout shops buying companies that run clinical trials for pharma and biotech companies.

These so-called contract research organizations, or CROs, are expected to expand and consolidate, making it highly likely we could see more LBOs. Click through below to see a selection of other noteworthy CROs, presented alphabetically, that could look attractive to sponsors. These include public companies that, like PPD, might find it easier to navigate the market’s consolidation under private ownership; public companies with recent changes at the CEO level; and private equity-owned companies, including one that’s been in its owner’s portfolio for almost four years now.

JLL Partners Selling C.H.I Overhead Doors After Nearly 7 Years

It looks like JLL Partners will be exiting C.H.I. Overhead Doors after nearly seven years.

Friedman Fleischer & Lowe is buying C.H.I. Overhead, a garage door maker, according to Standard & Poor’s LCD. Friedman Fleischer is in the market for a $203.5 million loan to back its by of C.H.I., LCD said. GE Capital and Wells Fargo are financing the deal, Thomson Reuters Loan Pricing Corp. said.

The Deal, which reported the C.H.I sale last week, said the transaction was valued at roughly $290 million.

PEHUB Community

Join the 12500 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget